Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Sturm

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Immunopharmacology|April 1, 1992
Strategies for the development of new antiarthritic agentsA J Lewis, K B Glaser, R J Sturm, et al.
Agents and Actions|January 1, 1993
VLA-4-dependent adhesion activities of U937 cells and guinea pig bronchoalveolar lavage leukocytesD A Monshizadegan, D A Holloway, J M Torrente, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactionsB M Weichman, J W Berkenkopf, D Grimes, et al.
Cancer Research|October 1, 1983
Antagonist of phorbol ester receptor-mediated chemotaxis in mouse peritoneal macrophagesR J Sturm, B M Smith, R W Lane, et al.
Agents and Actions|June 1, 1989
Potential regulatory role of inflammatory cells on local vascular smooth muscle toneR J Sturm, D A Holloway, S Buckley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factorT J Rimele, R J Sturm, L M Adams, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Immunopharmacology|April 1, 1992
Strategies for the development of new antiarthritic agentsA J Lewis, K B Glaser, R J Sturm, et al.
Agents and Actions|January 1, 1993
VLA-4-dependent adhesion activities of U937 cells and guinea pig bronchoalveolar lavage leukocytesD A Monshizadegan, D A Holloway, J M Torrente, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactionsB M Weichman, J W Berkenkopf, D Grimes, et al.
Cancer Research|October 1, 1983
Antagonist of phorbol ester receptor-mediated chemotaxis in mouse peritoneal macrophagesR J Sturm, B M Smith, R W Lane, et al.
Agents and Actions|June 1, 1989
Potential regulatory role of inflammatory cells on local vascular smooth muscle toneR J Sturm, D A Holloway, S Buckley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factorT J Rimele, R J Sturm, L M Adams, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Pageof 2